# RA Effect on Cell Surface Molecules in Vivo

> **NCT03753867** · PHASE1 · WITHDRAWN · sponsor: **Ottawa Hospital Research Institute**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Acitretin

## Key facts

- **NCT ID:** NCT03753867
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-07
- **Primary completion:** 2019-05-08
- **Final completion:** 2019-05-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn.
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03753867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03753867, "RA Effect on Cell Surface Molecules in Vivo". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03753867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*